The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

Pliant plans to submit the full outcomes from the BEACON-IPF trial for future publication. Credit: Lana Leon/Shutterstock. Pliant Therapeutics has discontinued the bexotegrast development for ...

Tango Therapeutics is focused on advancing precision medicine for cancer treatment. Credit: MacroEcon/Shutterstock. Tango Therapeutics has dosed the first subject in the Phase I/II trial assessing ...

The lead investigator is calling on more research into the drug’s safety profile and cost-effectiveness as a treatment for depression. Image credit: My Ocean Production / Shutterstock. A Parkinson’s ...

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).

Lipocine has initiated subject dosing in a two-arm, blinded, randomised Phase III trial of LPCN 1154 for postpartum ...

Pfizer has reported positive topline outcomes from the multicentre, open-label Phase III BASIS trial of Hympavzi.

Viatris’ presbyopia drug MR-141 (phentolamine ophthalmic solution 0.75%) has met the primary endpoint and all secondary ...

The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM: the US, France, ...

Viking Therapeutics has begun the VANQUISH Phase III clinical programme of VK2735, intended for the potential treatment of ...

Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women ...

Kashiv has reported positive topline outcomes from the confirmatory trial of the proposed biosimilar to Novartis’ Xolair, ADL ...